Intercept Pharmaceuticals In shares owned by Smith Asset Management Group
Quarter-by-quarter ownership of Intercept Pharmaceuticals In shares owned by Smith Asset Management Group
from 13F filings
Historical chart of Smith Asset Management Group investment in Intercept Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Intercept Pharmaceuticals In held by Smith Asset Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Intercept Pharmaceuticals In by Smith Asset Management Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2021-06-30 | $999 | 30 | 33.33 |
2021-03-31 | $999 | 30 | 33.33 |
2020-12-31 | $25k | 1.0k | 24.27 |
2020-09-30 | $43k | 1.0k | 41.75 |
2020-06-30 | $49k | 1.0k | 47.57 |
2020-03-31 | $66k | 1.1k | 62.86 |
2019-12-31 | $130k | 1.1k | 123.81 |
2019-09-30 | $70k | 1.1k | 66.67 |
2019-06-30 | $50k | 630 | 79.37 |
2019-03-31 | $70k | 630 | 111.11 |
2018-12-31 | $285k | 2.8k | 100.71 |
2018-09-30 | $370k | 2.9k | 126.28 |
2013-12-31 | $1.7M | 25k | 68.29 |
2013-09-30 | $1.7M | 25k | 69.04 |
More positions owned by Smith Asset Management Group
View all positions for Smith Asset Management Group